BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35721082)

  • 1. Multi-Omics Integrative Analysis of Lung Adenocarcinoma: An
    Ruan X; Ye Y; Cheng W; Xu L; Huang M; Chen Y; Zhu J; Lu X; Yan F
    Front Med (Lausanne); 2022; 9():894338. PubMed ID: 35721082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular classification reveals the sensitivity of lung adenocarcinoma to radiotherapy and immunotherapy: multi-omics clustering based on similarity network fusion.
    Zhang J; Li Y; Dai W; Tang F; Wang L; Wang Z; Li S; Ji Q; Zhang J; Liao Z; Yu J; Xu Y; Gong J; Hu J; Li J; Guo X; He F; Han L; Gong Y; Ouyang W; Wang Z; Xie C
    Cancer Immunol Immunother; 2024 Mar; 73(4):71. PubMed ID: 38430394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular cluster mining of high-grade serous ovarian cancer via multi-omics data analysis aids precise medicine.
    Cai D; Liu T; Fang J; Liu Y
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):9151-9165. PubMed ID: 37178426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-omics consensus portfolio to refine the classification of lung adenocarcinoma with prognostic stratification, tumor microenvironment, and unique sensitivity to first-line therapies.
    Zou Y; Cao C; Wang Y; Zhou Y; Yao S; Zhang L; Zheng K; Zhang H; Qin W; Qin K; Xiong H; Yuan X; Fu S; Wang Y; Xiong H
    Transl Lung Cancer Res; 2022 Nov; 11(11):2243-2260. PubMed ID: 36519025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular classification reveals the diverse genetic and prognostic features of gastric cancer: A multi-omics consensus ensemble clustering.
    Hu X; Wang Z; Wang Q; Chen K; Han Q; Bai S; Du J; Chen W
    Biomed Pharmacother; 2021 Dec; 144():112222. PubMed ID: 34607103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and validation of immunotherapy for four novel clusters of colorectal cancer based on the tumor microenvironment.
    Zheng X; Ma Y; Bai Y; Huang T; Lv X; Deng J; Wang Z; Lian W; Tong Y; Zhang X; Yue M; Zhang Y; Li L; Peng M
    Front Immunol; 2022; 13():984480. PubMed ID: 36389763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-omics cluster defines the subtypes of CRC with distinct prognosis and tumor microenvironment.
    Ma Y; Li J; Zhao X; Ji C; Hu W; Ma Y; Qu F; Sun Y; Zhang X
    Eur J Med Res; 2024 Mar; 29(1):207. PubMed ID: 38549156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune depletion of the methylated phenotype of colon cancer is closely related to resistance to immune checkpoint inhibitors.
    Zhong C; Xie T; Chen L; Zhong X; Li X; Cai X; Chen K; Lan S
    Front Immunol; 2022; 13():983636. PubMed ID: 36159794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-omics analysis of genomics, epigenomics and transcriptomics for molecular subtypes and core genes for lung adenocarcinoma.
    Zhao Y; Gao Y; Xu X; Zhou J; Wang H
    BMC Cancer; 2021 Mar; 21(1):257. PubMed ID: 33750346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signatures of Multi-Omics Reveal Distinct Tumor Immune Microenvironment Contributing to Immunotherapy in Lung Adenocarcinoma.
    Huang Z; Li B; Guo Y; Wu L; Kou F; Yang L
    Front Immunol; 2021; 12():723172. PubMed ID: 34539658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular subtypes based on ferroptosis-related genes and tumor microenvironment infiltration characterization in lung adenocarcinoma.
    Zhang W; Yao S; Huang H; Zhou H; Zhou H; Wei Q; Bian T; Sun H; Li X; Zhang J; Liu Y
    Oncoimmunology; 2021; 10(1):1959977. PubMed ID: 34527427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and clinical diversity in primary central nervous system lymphoma.
    Hernández-Verdin I; Kirasic E; Wienand K; Mokhtari K; Eimer S; Loiseau H; Rousseau A; Paillassa J; Ahle G; Lerintiu F; Uro-Coste E; Oberic L; Figarella-Branger D; Chinot O; Gauchotte G; Taillandier L; Marolleau JP; Polivka M; Adam C; Ursu R; Schmitt A; Barillot N; Nichelli L; Lozano-Sánchez F; Ibañez-Juliá MJ; Peyre M; Mathon B; Abada Y; Charlotte F; Davi F; Stewart C; de Reyniès A; Choquet S; Soussain C; Houillier C; Chapuy B; Hoang-Xuan K; Alentorn A
    Ann Oncol; 2023 Feb; 34(2):186-199. PubMed ID: 36402300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Typical tumor immune microenvironment status determine prognosis in lung adenocarcinoma.
    Ren C; Li J; Zhou Y; Zhang S; Wang Q
    Transl Oncol; 2022 Apr; 18():101367. PubMed ID: 35176624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma.
    Sun H; Liu SY; Zhou JY; Xu JT; Zhang HK; Yan HH; Huan JJ; Dai PP; Xu CR; Su J; Guan YF; Yi X; Yu RS; Zhong WZ; Wu YL
    EBioMedicine; 2020 Oct; 60():102990. PubMed ID: 32927274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crosstalk of four kinds of cell deaths defines subtypes of cutaneous melanoma for precise immunotherapy and chemotherapy.
    Wan Q; Wei R; Wei X; Deng YP
    Front Immunol; 2022; 13():998454. PubMed ID: 36532053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematical identifications of prognostic meaningful lung adenocarcinoma subtypes and the underlying mutational and expressional characters.
    Lv Z; Lei T
    BMC Cancer; 2020 Jan; 20(1):56. PubMed ID: 31987030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrative analysis reveals distinct subtypes with therapeutic implications in KRAS-mutant lung adenocarcinoma.
    Liu K; Guo J; Liu K; Fan P; Zeng Y; Xu C; Zhong J; Li Q; Zhou Y
    EBioMedicine; 2018 Oct; 36():196-208. PubMed ID: 30268834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prognosis-related molecular subtype for early-stage non-small lung cell carcinoma by multi-omics integration analysis.
    Yang K; Wu Y
    BMC Cancer; 2021 Feb; 21(1):128. PubMed ID: 33549049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic Effects of Different Levels of Genomic Data for the Staging of Lung Adenocarcinoma: An Illustrative Study.
    Li Y; Mansmann U; Du S; Hornung R
    Genes (Basel); 2021 Nov; 12(12):. PubMed ID: 34946821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGFR DNA Methylation Correlates With EGFR Expression, Immune Cell Infiltration, and Overall Survival in Lung Adenocarcinoma.
    Xu Z; Qin F; Yuan L; Wei J; Sun Y; Qin J; Deng K; Zheng T; Li S
    Front Oncol; 2021; 11():691915. PubMed ID: 34447695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.